Sleisenger and Fordtran’s Gastrointestinal and Liver Disease

Edited by Mark Feldman, Lawrence S Friedman, Lawrence J Brandt. Philadelphia: Saunders Elsevier, 2006, £180 (hardback), pp 1–1540 and 1541–2890. ISBN 1-4160-0245-6 The 8th edition of this famous textbook is the first not to be edited by either of the original editors and the 3rd edition to include hepatology as well as gastroenterology, with 38 of the 124 chapters focused on liver and biliary disease. This book thus provides a comprehensive reference for general gastroenterologists as well as more specialised practitioners in gastroenterology and hepatology. The two volumes are presented in a modern glossy style with clear figures and plenty of high-quality line drawings and tables which make the individual chapters easy to read. The first section on basic biology is relatively brief, but this is supplemented by introductions to the subsequent sections that include anatomical, embryological and developmental aspects for each organ. The book is multi-authored with 177 contributors, and …

[1]  Y. Maehara,et al.  Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. , 2006, Gastroenterology.

[2]  D. Steensma,et al.  JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained , 2006, Leukemia.

[3]  R. Lai,et al.  Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. , 2006, Blood.

[4]  P. Campbell,et al.  Mechanisms of Disease The Myeloproliferative Disorders , 2006 .

[5]  G. Mufti,et al.  Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. , 2005, Gastroenterology.

[6]  K. Venkatasubbarao,et al.  Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases. , 2005, Cancer research.

[7]  M. Stratton,et al.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. , 2007, The New England journal of medicine.

[8]  M. Tsuneyoshi,et al.  Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. , 2003, Cancer letters.

[9]  M. Vogelbaum,et al.  Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2. , 2005, Cancer research.

[10]  B. Wiedenmann,et al.  Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. , 2003, Gastroenterology.

[11]  Lin Zhu,et al.  Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro , 2006, Cancer science.